tenk.fyi

Oruka Therapeutics, Inc.

ORKANasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$105.4M

25.9% YoY

EPS

-

Cash

$46.9M

23.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro